$27MSeries B, 14 April 2026
Proceeds advance SPT-2101 and its MICS cochlear delivery platform, alongside a research collaboration with Advanced Bionics.
- Amount
- $27M
- Stage
- Series B
- Announced
- 14 April 2026
- Lead
- Gund Investment
- Other investors
- Advanced Bionics, Ferring Ventures, Uni-Bio Science Group
- Use of funds
- Proceeds advance SPT-2101 and its MICS cochlear delivery platform, alongside a research collaboration with Advanced Bionics.
- Checked
- Announced by the company
- Sources
- Spiral Therapeutics announces $27M Series B vcaonline.com
Spiral Therapeutics announces $27M Series B pulse2.com